Charlemagne Hobour, 52, is paralyzed on his left side and wheelchair bound for life after Catholic Health’s St. Joseph ...

LEQEMBI IQLIK, if approved for initiation dosing, would be the first and only anti-amyloid treatment to offer at-home ...

Nicholas Aderinto, MD does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

MONDAY, Nov. 25, 2024 (HealthDay News) -- Women, especially those who had high blood pressure during pregnancy or entered ...

Tenecteplase shows no benefit over standard care for 90-day functional recovery in patients with minor ischemic stroke and disabling deficits.

Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...

Hospitals are referring a larger share of stroke patients to inpatient rehabilitation facilities, which typically favor home health as the provider of any additional step-down care, a recent study ...

In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell ...

AI-Stroke, a France-based Software-as-a-Medical-Device (SaMD) company using artificial intelligence (AI) to develop an “ ...

Patients with symptomatic intracranial atherosclerosis who show impaired distal perfusion face a significantly higher risk for early stroke recurrence.